MARGARITA MARMOLEJO: Open Payments
NPI 1760035810 · VIRGINIA BEACH, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$729 in 28 payments from 10 companies in 2025. Trend: 2023 $348 · 2024 $372 · 2025 $729
Food & beverage: $729
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $161 |
| Novo Nordisk Inc | 2 | $145 |
| AstraZeneca Pharmaceuticals LP | 1 | $121 |
| Lilly USA, LLC | 4 | $73 |
| Janssen Pharmaceuticals, Inc | 3 | $60 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $59 |
| Otsuka America Pharmaceutical, Inc. | 2 | $41 |
| Collegium Pharmaceutical, Inc. | 1 | $25 |
| TMS NeuroHealth Centers Inc. | 1 | $22 |
| Axsome Therapeutics, Inc. | 1 | $21 |
Products named: VRAYLAR, Wegovy, AIRSUPRA, SPRAVATO, TRINTELLIX, MOUNJARO, REXULTI, Jornay PM.
Industry payments across VA — which companies pay providers there.
